Levobupivacaine: A review of its pharmacology and use as a local anaesthetic

Drugs

Volumn 59, Issue 3, 2000, Pages 551-579

  Foster, Rachel H ^a   Markham, Anthony ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CLONIDINE; CYTOCHROME P450 3A4; FENTANYL; ITRACONAZOLE; LEVOBUPIVACAINE; MORPHINE; ROPIVACAINE;

ANALGESIC ACTIVITY; CARDIOTOXICITY; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG METABOLISM; DRUG POTENCY; DRUG TOLERABILITY; HUMAN; HYPOTENSION; LABOR; NAUSEA; NERVE BLOCK; NONHUMAN; PERIBULBAR ANESTHESIA; POSTOPERATIVE PAIN; REVIEW; SURGICAL AND OBSTETRIC CARE; VASOCONSTRICTION;

ANIMALIA;

EID: 0034008060     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059030-00013     Document Type: Review

References (71)

1. 1. McCaughey W, Mirakhur RK. Drugs in anaesthetic practice and analgesia. In: Speight TM, Holford NHG, editors. Avery's drug treatment. 4th ed. Auckland: Adis International, 1997: 451-514
2. 2. British National Formulary. No. 38. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1999
3. 3. Albaladejo P, Bouaziz H, Benhamou D. Epidural analgesics: how can safety and efficacy be improved? CNS Drugs 1998 Aug; 10: 91-104
4. 4. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979; 51 (4): 285-6
5. 5. Heath ML. Deaths after intravenous regional anaesthesia. BMJ 1982 Oct 2; 285: 913-4
6. 6. Åberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol et Toxicol 1972; 31: 273-86
7. 7. Luduena FP, Bogado EF, Tullar BF. Optical isomers of mepivacaine and bupivacaine. Arch Int Pharmacodyn 1972; 200: 359-69
8. 8. McClellan KJ, Spencer CM. Levobupivacaine. Drugs 1998 Sep; 56: 355-62
9. 9. Gristwood RW, Greaves JL. Levobupivacaine: a new safer long acting local anaesthetic agent. Expert Opin Invest Drug 1999 Jun; 8: 861-76
10. 10. Dyhre H, Lang M, Wallin R, et al. The duration of action of bupivacaine, levobupivacaine, ropivacaine and pethidine in peripheral nerve block in the rat. Acta Anaesthesiol Scand 1997 Nov; 41: 1346-52
11. 11. Kanai Y, Tateyama S, Nakamura T, et al. Effects of levobupivacaine, bupivacaine, and ropivacaine on tail-flick response and motor function in rats following epidural or intrathecal administration. Region Anesth Pain Med 1999 Sep-Oct; 24: 444-52
12. 12. Bardsley H, Gristwood R, Watson N, et al. The local anaesthetic activity of levobupivacaine does not differ from racemic bupivacaine (Marcain): first clinical evidence. Expert Opin Invest Drug 1997 Dec; 6: 1883-5
13. 13. Lyons G, Columb M, Wilson RC. Epidural pain relief in labour: potencies of levobupivacaine and racemic bupivacaine. Br J Anaesth 1998 Dec; 81: 899-901
14. 14. Robinson APC, Lyons GR, Wilson RC, et al. Levobupivacaine for extradural analgesia in labour; the sparing effect of extradural fentanyl [abstract]. Br J Anaesth 1999 Jun; 82 Suppl. 1: 208
15. 15. Aps C, Reynolds F. An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. Br J Clin Pharmacol 1978; 6: 63-8
16. 16. Morrison SG, Dominguez JJ, Frascarolo P, et al. Cardiotoxic effects of levobupivacaine, bupivacaine and ropivacaine - an experimental study in pentobarbital anesthetized swine [abstract]. Region Anesth Pain Med 1998 May-June; 23 (3 Suppl.): 50
17. 17. Burke D, MacKenzie M, Newton, D, et al. A comparison of vasoactivity between levobupivacaine and bupivacaine [abstract]. Br J Anaesth 1998; 81 (4): 631P-2P
18. 18. Santos AC, Karpel B, Noble G. The placental transfer and fetal effects of levobupivacaine, racemic bupivacaine, and ropivacaine. Anesthesiology 1999 Jun; 90: 1698-703
19. 19. Fernandes L, Simonetti MPB. Vascular effects of S(-) bupivacaine, RS(±) bupivacaine and ropivacaine on isolated strips of human umbilical vein: preliminary results [abstract]. Reg Anesth 1997 Mar-Apr; 22 Suppl.: 65
20. 20. Valenzuela C, Snyders DJ, Bennett PB, et al. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation 1995; 92: 3014-24
21. 21. Huang YF, Pryor ME, Mather LE, et al. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998; 86: 797-804
22. 22. Vanhoutte F, Vereecke J, Verbeke N, et al. Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea pig papillary muscle. Br J Pharmacol 1991; 103: 1275-81
23. 23. Valenzuela C, Delpón H, Tamkun MM, et al. Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. Biophys J 1995; 69: 418-27
24. 24. Harding DP, Collier PA, Huckle RM, et al. Cardiotoxic effects of levobupivacaine, bupivacaine and ropivacaine: an in vitro study in guinea-pig and human cardiac muscle [abstract]. Br J Pharmacol 1998 Dec; 125 Suppl.: 127P
25. 25. Graf BM, Martin E, Bosnjak ZJ, et al. Stereospecific effect of bupivacaine isomers on atrioventricular conduction in the isolated perfused guinea pig heart. Anesthesiology 1997 Feb; 86 (2): 410-9
26. 26. Mazoit JX, Boïco O, Samii K. Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993; 77: 477-82
27. 27. Mazoit JX, Decaux J, Bouaziz H, et al. Comparative effect of racemic bupivacaine, levobupivacaine and ropivacaine on isolated rabbit heart [abstract]. Anesthesiology 1999 Sep; 91 (3A): A885
28. 28. Simonetti MPB, Fernandes L. S(-) bupivacaine and RS(±) bupivacaine: a comparison of effects on the right and left atria of the rat [abstract]. Reg Anesth 1997 Mar-Apr; 22 Suppl.: 58
29. 29. Graf BM, Eberl S, Abraham I, et al. Comparison of the direct cardiotoxicity of the isomers of ropivacaine and bupivacaine [abstract]. Anesthesiology 1998 Sep; 89 (3A Suppl.): A876
30. 30. Denson DD, Behbebani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992 Nov-Dec; 17: 311-6
31. 31. Chang DHT, Mather LE, Ladd LA, et al. Effects of high doses of levobupivacaine on the cardiovascular and central nervous systems of the sheep [abstract]. Proceedings of the Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 1997 Dec; 4: 76
32. 32. Santos AC. Comparative systemic toxicity of levobupivacaine, bupivacaine and ropivacaine during ovine pregnancy [abstract]. Anesth Analg 1999 Feb; 88 Suppl.: S265
33. 33. Ericson A-C, Avesson M. Effects of ropivacaine, bupivacaine and S(-)-bupivacaine on the ECG after rapid TV injections to conscious rats [poster]. International Monitor on Regional Anaesthesia 1996; 8 (2): 51
34. 34. Bardsley H, Gristwood R, Baker H, et al. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1998 Sep; 46: 245-9
35. 35. Nimmo W. Evidence of improved safety over bupivacaine in human volunteers [abstract]. European Society of Anaesthesiologists. 1998 Apr 25-28; Barcelona, Spain
36. 36. Burke D, Henderson DJ, Simpson AM, et al. Comparison of 0.25% S(-)-bupivacaine with 0.25% RS-bupivacaine for epidural analgesia in labour. Br J Anaesth 1999; 83 (5): 750-5
37. 37. Bader AM, Tsen LC, Camann WR, et al. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999 Jun; 90: 1596-601
38. 38. Cox CR, Faccenda KA, Gilhooly C, et al. Extradural S(-)-bupivacaine: comparison with racemic RS-bupivacaine. Br J Anaesth 1998 Mar; 80: 289-93
39. 39. Cox CR, Checketts, MR, MacKenzie N, et al. Comparison of S(-)-bupivacaine with racemic (RS)-bupivacaine in supra-clavicular brachial plexus block. Br J Anaesth 1998; 80: 594-8
40. 40. Gunter JB, Gregg T, Varughese AM, et al. Levobupivacaine for ilioinguinal/iliohypogastric nerve block in children. Anesth Analg 1999 Sep; 89: 647-9
41. 41. McLure HA, Rubin AP. Comparison of 0.75% levobupivacaine with 0.75% racemic bupivacaine for peribulbar anaesthesia. Anaesthesia 1998 Dec; 53: 1160-4
42. 42. Kopacz DJ, Allen HW, Thompson GE. A comparison of epidural levobupivacaine 0.75% with racemic bupivacaine for lower abdominal surgery. Anesth Analg 2000; 90: 642-8
43. 43. Van F, Rolan PE, Brennan N, et al. Differential effects of levo-and racemic bupivacaine on the EEG in volunteers [abstract]. Region Anesth Pain Med 1998 May-Jun; 23 Suppl.: 48
44. 44. Purdue Pharma L.P. Chirocaine (levobupivacaine injection) prescribing information. Norwalk (CT), USA, 1 Dec 1999
45. 45. Faccenda KA, Morrison LMM. The pharmacokinetics of levobupivacaine and racemic bupivacaine following extradural administration [abstract]. Region Anesth Pain Med 1998 May-Jun; 23 Suppl.: 52
46. 46. Abbott Laboratories. Chirocaine 2.5 mg/ml: summary of product characteristics. Cambridge, UK, 1999
47. 47. Thomas JM, Schug SA. Recent advances in the pharmacokinetics of local anaesthetics: long-acting amide enantiomers and continuous infusions. Clin Pharmacokinet 1999 Jan; 36: 67-83
48. 48. Mather M, McCall P, McNicol PL. Bupivacaine enantiomer pharmacokinetics after intercostal neural blockade in liver transplantation patients. Anesth Analg 1995; 80: 328-35
49. 49. Palkama VJ, Neuvonen PJ, Olkkola KT. Effect of itraconazole on the pharmacokinetics of bupivacaine enantiomers in healthy volunteers. Br J Anaesth 1999; 83 (4): 659-61
50. 50. Groen K, Mantel M, Zeijlmans PWM, et al. Pharmacokinetics of the enantiomers of bupivacaine and mepivacaine after epidural administration of the racemates. Anesth Analg 1998; 86: 361-6
51. 51. Burm AGL, van der Meer AD, van Kleef JW, et al. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994 Aug; 38: 125-9
52. 52. Crews JC, Foreman AS, Weller RS, et al. Onset, duration, and dose tolerability of levobupivacaine 0.5% for axillary brachial plexus neural blockade [abstract]. Anesthesiology 1998 Sep; 89 (3A) Suppl.: A894
53. 53. Convery PN, Weir P, Quinn P, et al. Epidural levobupivacaine for hip arthroplasty anesthesia and analgesia. Region Anesth Pain Med 1998 May-Jun; 23 Suppl.: 86
54. 54. Carr D. Levobupivacaine for postoperative pain management: new strategics [symposia presentation]. In: From anesthesia to analgesia: a single agent. Abingdon, Oxfordshire: TMG Healthcare Communications, 1999: 9-11
55. 55. Burke D, Kennedy S, Bannister J. Spinal Anesthesia with 0.5% s(≡)-bupivacaine for elective lower limb surgery. Region Anesth Pain Med 1999; 24 (6): 519-23
56. 56. Convery P, Burke D, Donaldson L, et al. Comparison of 0.125% levobupivacaine and 0.125% bupivacaine epidural infusions for labour analgesia [abstract]. Br J Anaesth 1999 Jun; 82 Suppl. 1: 163
57. 57. Convery PN, Milligan KR, Weir P, et al. The efficacy and safety of epidural infusions of levobupivacaine with and without clonidine for post-operative pain relief in patients undergoing total hip replacement. Anesthesiology 1998 Sep; 89 (3A Suppl.): A850
58. 58. Kopacz DJ, Sharrock NE, Allen HW. A comparison of levobupivacaine 0.125%, fentanyl 4 μg/mL, or their combination for patient-controlled epidural analgesia after major orthopedic surgery. Anesth Analg 1999; 89: 1497-503
59. 59. Dickson U, Murdoch J, Wilson P, et al. The efficacy and safety of levobupivacaine administered as a continuous epidural infusion for post-operative analgesia in patients undergoing elective orthopaedic surgery [abstract]. Region Anesth Pain Med 1999 May-Jun; 24 Suppl.: 18
60. 60. Crews JC, Hord AH, Denson DD, et al. A comparison of the analgesic efficacy of 0.25% levobupivacaine combined with 0.005% morphine, 0.25% levobupivacaine alone, or 0.005% morphine alone for the management of postoperative pain in patients undergoing major abdominal surgery. Anesth Analg 1999; 89: 1504-9
61. 61. Bay-Nielsen M, Klarskov B, Bech K, et al. Levobupivacaine vs bupivacaine as infiltration anaesthesia in inguinal herniorrhaphy. Br J Anaesth 1999 Feb; 82 (2): 280-2
62. 62. Kingsnorth A, Bennett D, Cummings C, et al. A randomised, double-blind study to compare the efficacy of 0.25% levobupivacaine with 0.25% bupivacaine (racemic) infiltration anaesthesia in elective inguinal hernia repair. Region Anesth Pain Med 1998 May-Jun; 23 Suppl.: 106
63. 63. Carr DB, Sternlicht A, Carabuena J, et al. Preemptive inter-scalene block for elective, short-stay shoulder surgery: loss of early benefits by one week after discharge [abstract]. Anesthesiology 1999 Sep; 91 Suppl.: A943
64. 64. Stead SW. Innovations in ophthalmic anesthesia. Anesth Analg 1998 Mar; 86 Suppl.: 128-38
65. 65. O'Sullivan EP. Comparison of 0.75% levobupivacaine with 0.75% racemic bupivacaine for peribulbar anaesthesia [letter]. Anaesthesia 1999 Jun; 54: 610
66. 66. Curatolo M, Scaramozzino P, Venuti FS, et al. Factors associated with hypotension and bradycardia after epidural blockade. Anesth Analg 1996; 83: 1033-40
67. 67. Kopacz DJ, Allen HW. Accidental intravenous levobupivacaine. Anesth Analg 1999 Oct; 89: 1027-9
68. 68. Yun EM, Meadows W, Santos AC. New amide local anaesthetics for obstetric use. Baillieres Clin Obstet Gynaecol 1998 Sep; 12: 461-71
69. 69. Markham A, Faulds D. Ropivacaine: a review of its pharmacology and therapeutic use in regional anesthesia. Drugs 1996 Sep; 52 (3): 429-49
70. 70. Polley LS, Columb MO, Naughton NN, et al. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labour. Anesthesiology 1999; 90: 944-50
71. 71. Capogna G, Celleno D, Fusco P, et al. Relative potencies of bupivacaine and ropivacaine for analgesia in labour. Br J Anaesth 1999; 82 (3): 371-3